Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.

Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M.

Neuromolecular Med. 2013 Sep;15(3):458-69. doi: 10.1007/s12017-013-8232-3. Epub 2013 May 12.

PMID:
23666762
2.

Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.

Gu GJ, Wu D, Lund H, Sunnemark D, Kvist AJ, Milner R, Eckersley S, Nilsson LN, Agerman K, Landegren U, Kamali-Moghaddam M.

J Alzheimers Dis. 2013;33(3):699-713. doi: 10.3233/JAD-2012-121357.

PMID:
23001711
3.

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.

Lund H, Gustafsson E, Svensson A, Nilsson M, Berg M, Sunnemark D, von Euler G.

Acta Neuropathol Commun. 2014 Feb 17;2:22. doi: 10.1186/2051-5960-2-22.

4.

Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.

Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH.

J Neurosci. 2005 Jul 13;25(28):6584-93.

5.
6.

Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.

Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheelock TR, Yanagawa H, Imahori K, Nixon RA.

Brain Res. 1996 Oct 21;737(1-2):119-32.

PMID:
8930358
7.
8.

Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.

Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI.

J Neurosci. 2004 Sep 8;24(36):7895-902.

9.

Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.

Wang ZH, Liu P, Liu X, Manfredsson FP, Sandoval IM, Yu SP, Wang JZ, Ye K.

Mol Cell. 2017 Sep 7;67(5):812-825.e5. doi: 10.1016/j.molcel.2017.07.018. Epub 2017 Aug 17.

PMID:
28826672
10.

Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain.

Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G, Terstappen GC, Nicoletti F.

J Neurosci. 2004 Jun 30;24(26):6021-7.

11.
12.

Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Annadurai N, Agrawal K, Džubák P, Hajdúch M, Das V.

Cell Mol Life Sci. 2017 Nov;74(22):4159-4169. doi: 10.1007/s00018-017-2574-1. Epub 2017 Jun 20. Review.

PMID:
28634681
14.

A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.

Yu W, Polepalli J, Wagh D, Rajadas J, Malenka R, Lu B.

Hum Mol Genet. 2012 Mar 15;21(6):1384-90. doi: 10.1093/hmg/ddr576. Epub 2011 Dec 8.

15.

Signaling from MARK to tau: regulation, cytoskeletal crosstalk, and pathological phosphorylation.

Timm T, Matenia D, Li XY, Griesshaber B, Mandelkow EM.

Neurodegener Dis. 2006;3(4-5):207-17.

PMID:
17047359
16.

Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.

Takahashi M, Uchikado H, Caprotti D, Weidenheim KM, Dickson DW, Ksiezak-Reding H, Pasinetti GM.

J Neuropathol Exp Neurol. 2006 Dec;65(12):1157-69. Erratum in: J Neuropathol Exp Neurol. 2007 Jan;66(1):100.

PMID:
17146290
17.

Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.

Mondragón-Rodríguez S, Basurto-Islas G, Santa-Maria I, Mena R, Binder LI, Avila J, Smith MA, Perry G, García-Sierra F.

Int J Exp Pathol. 2008 Apr;89(2):81-90. doi: 10.1111/j.1365-2613.2007.00568.x.

18.

A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.

Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, Binder LI, Kuret J.

Am J Pathol. 1999 Oct;155(4):1163-72.

19.

Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function.

Kim BM, You MH, Chen CH, Lee S, Hong Y, Hong Y, Kimchi A, Zhou XZ, Lee TH.

Cell Death Dis. 2014 May 22;5:e1237. doi: 10.1038/cddis.2014.216.

20.

14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.

Sugimori K, Kobayashi K, Kitamura T, Sudo S, Koshino Y.

Psychiatry Clin Neurosci. 2007 Apr;61(2):159-67.

Supplemental Content

Support Center